Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Mutation Research|July 5, 1996
Comparative synchronous fluorescence spectrophotometry and 32P-postlabeling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutationsA Andreassen, E H Kure, P S Nielsen, et al.Mutation Research|September 6, 2001
Genetic susceptibility and environmental estrogen-like compoundsV N Kristensen, E H Kure, B Erikstein, et al.Environmental Health Perspectives|September 1, 1995
Biological monitoring of polycyclic aromatic hydrocarbon exposure in a highly polluted area of PolandS Ovrebø, P E Fjeldstad, E Grzybowska, et al.Molecular Oncology|October 15, 2013
Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatmentJ B Kjersem, T Ikdahl, O C Lingjaerde, et al.Carcinogenesis|October 1, 1996
p53 mutations in lung tumours: relationship to gender and lung DNA adduct levelsE H Kure, D Ryberg, A Hewer, et al.Occupational and Environmental Medicine|January 10, 1998
Benzo(a)pyrene-albumin adducts in humans exposed to polycyclic aromatic hydrocarbons in an industrial area of PolandE H Kure, A Andreassen, S Ovrebø, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patientsV Skaug, D Ryberg, E H Kure, et al.BMC Cancer|July 2, 2025
Elevated KRAS protein level is associated with better survival in pancreatic cancerS M Stålberg, L Silwal-Pandit, J Hamfjord, et al.Carcinogenesis|March 1, 1997
p53 gene mutation analysis in tumors of patients exposed to alpha-particlesM Hollstein, H Bartsch, H Wesch, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trendsM F Ystgaard, T Å Myklebust, J Smeby, et al.Pageof 2